{"symbol":"PFE","fiscalQuarter":"Q4-2020","reportDate":"2021-02-02","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q4-2020","postBrief":{"headline":"Pfizer Misses on EPS \u2014 Stock Down 2.26%","keyNumbers":[{"metric":"EPS","actual":"$0.42","expected":"N/A","surprise":"-7.69%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management noted challenges in meeting EPS expectations.","There was no guidance provided for future quarters."],"summary":"Management expressed concerns about the current market conditions affecting performance. They did not provide any forward guidance, indicating uncertainty."},"guidanceChanges":{"summary":"No guidance data is available for future performance.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a miss on EPS, which contributed to a 2.26% decline in stock price. The lack of revenue data and forward guidance adds to investor uncertainty. Overall, the company faces challenges that may impact its performance in the near term.","metaDescription":"Pfizer (PFE) Q4 2020 earnings: EPS missed expectations. Stock down 2.26%. Full breakdown."}}